Page last updated: 2024-11-06

diethylenetriaminepenta(methylenephosphonic) acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Diethylenetriaminepenta(methylenephosphonic) acid (DTPMPA) is a powerful chelating agent. It is a white solid that is soluble in water and has a high affinity for metal ions, particularly calcium. DTPMPA is used in a variety of applications, including: water treatment, where it is used to prevent scale formation in boilers and cooling towers; agriculture, where it is used as a fertilizer and a soil amendment; and medicine, where it is used as a drug to treat hypercalcemia and to remove heavy metals from the body.'

diethylenetriaminepenta(methylenephosphonic) acid: RN given refers to parent cpd; used with 113mIn for bone scanning [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID85128
SCHEMBL ID22924
MeSH IDM0126013

Synonyms (38)

Synonym
diethylenetriaminepenta(methylenephosphonic) acid
phosphonic acid, [[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-
[(bis{2-[bis(phosphonomethyl)amino]ethyl}amino)methyl]phosphonic acid
15827-60-8
[bis[2-[bis(phosphonomethyl)amino]ethyl]amino]methylphosphonic acid
A809915
einecs 239-931-4
unii-0q75589tm3
(((phosphonomethyl)imino)bis(ethane-2,1-diylnitrilobis(methylene)))tetrakisphosphonic acid
phosphonic acid, (((phosphonomethyl)imino)bis(2,1-ethanediylnitrilobis(methylene)))tetrakis-
0q75589tm3 ,
phosphonic acid, p,p',p'',p'''-(((phosphonomethyl)imino)bis(2,1-ethanediylnitrilobis(methylene)))tetrakis-
diethylenetriamine, pentamethylenepentaphosphonic acid
ec 239-931-4
diethylenetriaminepenta(methylene-phosphonic acid)
dtpmp
FT-0624891
phosphonic acid, ((bis(2-(bis(phosphonomethyl)amino)ethyl)amino)methyl)-
diethylenetriamine-n,n,n',n'',n''-penta(methylenephosphonic acid)
phosphonic acid, (((phosphonomethyl)imino)bis(2,1- ethanediylnitrilobis(methylene)))tetrakis-
sequion 40 h 50
ethylenetriaminepenta(methylenephosphonic acid)
versenate ps
diethylenetriaminepenta(methylenephosphonic acid)
diethylenetriamine-n,n,n',n'',n''-pentakis(methylenephosphonic acid)
diethylenetriamine pentamethylene phosphonic acid [inci]
diethylenetriamine-pentakis(methylenephosphonic) acid
diethylenetriamine pentamethylene phosphonic acid
AKOS025310980
SCHEMBL22924
DTXSID0027775
mfcd00129718
J-009490
244775-22-2
Q3011490
67774-91-8
phosphonic acid,[[(phosphonomethyl)imino]bis[2,1-ethanediylnitrilobis(methylene)]]tetrakis-
F71190

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" The Cd-chelate complexes proved highly more toxic compared to Mn-chelate complexes or uncomplexed chelates exhibiting LC(50) values of 130-200 microg/L."( The acute toxicity of gluconic acid, beta-alaninediacetic acid, diethylenetriaminepentakismethylenephosphonic acid, and nitrilotriacetic acid determined by Daphnia magna, Raphidocelis subcapitata, and Photobacterium phosphoreum.
Dhondup, P; Pirkanniemi, K; Sillanpää, M, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's1 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.37 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.77 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]